Another study proposed a possibility that MDSCs generated in the spleen of tumor-bearing mice could induce dysregulation of surface molecules important for T cell tissue and lymph node trafficking such as CD44, CD69, and CD62L, thereby inhibiting T cell activation [256]. This evidence concerns the gene SELL and neoplasm.